Search research articles
Contact Us
Filters
Showing results (91-100 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]
Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
Haematologica
|
December 15, 2018
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
Michael J Burke, Wanda L Salzer, Meenakshi Devidas, et al.
Haematologica
|
February 17, 2022
Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial
Erin M Guest, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer
|
February 9, 2021
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group
Rachel E Rau, Yunfeng Dai, Meenakshi Devidas, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Pediatric Blood & Cancer
|
September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group
Jennifer L McNeer, Meenakshi Devidas, Yunfeng Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials
Elizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434
Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Clinical Pharmacology and Therapeutics
|
March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity
Yiwei Liu, Wenjian Yang, Colton A Smith, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]
Deepa Bhojwani, Huining Kang, Renee X Menezes, et al.
Haematologica
|
December 15, 2018
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG
Michael J Burke, Wanda L Salzer, Meenakshi Devidas, et al.
Haematologica
|
February 17, 2022
Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial
Erin M Guest, John A Kairalla, Joanne M Hilden, et al.
Pediatric Blood & Cancer
|
February 9, 2021
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group
Rachel E Rau, Yunfeng Dai, Meenakshi Devidas, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Pediatric Blood & Cancer
|
September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group
Jennifer L McNeer, Meenakshi Devidas, Yunfeng Dai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials
Elizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434
Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Clinical Pharmacology and Therapeutics
|
March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity
Yiwei Liu, Wenjian Yang, Colton A Smith, et al.
Page
of 16